Innate Pharma SA (IPHA)
1.65
-0.04
(-2.37%)
USD |
NASDAQ |
Apr 16, 13:46
Innate Pharma Research and Development Expense (Annual) : 46.11M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Nicox SA | 6.446M |
| DBV Technologies SA | 107.12M |
| Cellectis SA | 75.08M |
| Transgene SA | 36.70M |
| Adocia SA | -- |